ARCHIVES

Gramm-Rudman Cut Facing NCI Could Take $85 Million

This article is from The Cancer Letter archive.

Vol. 15 No. 40 | October 20, 1989

Download PDF Visit The Full Archive

Related Articles

Colorectal Cancer Incidence Rising Worldwide

June 12, 2009

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013